Recent Highlights

Scientists in Manchester have demonstrated the potential of a form of graphene – graphene oxide - as a non-toxic agent to target and neutralise cancer stem cells.

Our blood cancer researchers have been investigating an innovative method to monitor the effect of anti-cancer drugs on rare leukaemia cells and trialling a new approach to create blood cells in the laboratory.

Finally, a study by the Nanomedicine group found that heat-activated drug parcels were more effective at delivering their contents to tumour cells – leading to improved survival rates.